Compare Cadila Healthcare with Aurobindo Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs AUROBINDO PHARMA - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

AUROBINDO PHARMA 
   Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE AUROBINDO PHARMA CADILA HEALTHCARE/
AUROBINDO PHARMA
 
P/E (TTM) x 18.0 9.8 182.6% View Chart
P/BV x 2.4 1.8 132.3% View Chart
Dividend Yield % 1.4 0.6 247.5%  

Financials

 CADILA HEALTHCARE   AUROBINDO PHARMA
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-19
AUROBINDO PHARMA
Mar-19
CADILA HEALTHCARE/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs432830 52.1%   
Low Rs306527 58.1%   
Sales per share (Unadj.) Rs128.6333.9 38.5%  
Earnings per share (Unadj.) Rs18.540.4 46.0%  
Cash flow per share (Unadj.) Rs24.451.8 47.1%  
Dividends per share (Unadj.) Rs3.502.50 140.0%  
Dividend yield (eoy) %0.90.4 257.2%  
Book value per share (Unadj.) Rs101.5237.1 42.8%  
Shares outstanding (eoy) m1,023.74585.91 174.7%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x2.92.0 141.3%   
Avg P/E ratio x19.916.8 118.5%  
P/CF ratio (eoy) x15.113.1 115.5%  
Price / Book Value ratio x3.62.9 127.2%  
Dividend payout %18.96.2 304.6%   
Avg Mkt Cap Rs m378,170397,569 95.1%   
No. of employees `00012.417.9 69.7%   
Total wages/salary Rs m21,24125,849 82.2%   
Avg. sales/employee Rs Th10,585.010,956.9 96.6%   
Avg. wages/employee Rs Th1,707.81,447.7 118.0%   
Avg. net profit/employee Rs Th1,526.51,324.3 115.3%   
INCOME DATA
Net Sales Rs m131,656195,636 67.3%  
Other income Rs m2,0111,553 129.5%   
Total revenues Rs m133,667197,189 67.8%   
Gross profit Rs m29,73139,519 75.2%  
Depreciation Rs m5,9866,680 89.6%   
Interest Rs m1,9352,626 73.7%   
Profit before tax Rs m23,82131,767 75.0%   
Minority Interest Rs m46927 1,737.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-881 0.0%   
Tax Rs m5,3037,269 73.0%   
Profit after tax Rs m18,98723,645 80.3%  
Gross profit margin %22.620.2 111.8%  
Effective tax rate %22.322.9 97.3%   
Net profit margin %14.412.1 119.3%  
BALANCE SHEET DATA
Current assets Rs m84,981153,645 55.3%   
Current liabilities Rs m73,425120,429 61.0%   
Net working cap to sales %8.817.0 51.7%  
Current ratio x1.21.3 90.7%  
Inventory Days Days75135 55.1%  
Debtors Days Days11064 172.0%  
Net fixed assets Rs m133,493103,909 128.5%   
Share capital Rs m1,024586 174.8%   
"Free" reserves Rs m102,839138,322 74.3%   
Net worth Rs m103,863138,908 74.8%   
Long term debt Rs m39,4971,800 2,194.9%   
Total assets Rs m234,831264,544 88.8%  
Interest coverage x13.313.1 101.6%   
Debt to equity ratio x0.40 2,935.5%  
Sales to assets ratio x0.60.7 75.8%   
Return on assets %8.99.9 89.7%  
Return on equity %18.317.0 107.4%  
Return on capital %18.323.8 76.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m48,40497,316 49.7%   
Fx outflow Rs m11,59340,589 28.6%   
Net fx Rs m36,81156,727 64.9%   
CASH FLOW
From Operations Rs m28,82316,220 177.7%  
From Investments Rs m-57,387-28,768 199.5%  
From Financial Activity Rs m18,84619,191 98.2%  
Net Cashflow Rs m-7,1056,656 -106.7%  

Share Holding

Indian Promoters % 74.8 54.1 138.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 8.0 104.4%  
FIIs % 5.9 27.7 21.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 10.2 107.8%  
Shareholders   44,069 69,601 63.3%  
Pledged promoter(s) holding % 0.0 8.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   DR. DATSONS LABS  DISHMAN PHARMA  J.B.CHEMICALS  JUBILANT LIFE SCIENCES  DIVIS LABORATORIES  

Compare CADILA HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 186 Points Higher; Energy and Power Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest during closing hours today and ended their day on a positive note.

Related Views on News

AUROBINDO PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 4.6% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, AUROBINDO PHARMA has posted a net profit of Rs 6 bn (up 4.6% YoY). Sales on the other hand came in at Rs 56 bn (up 17.9% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY20); Net Profit Down 79.3% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, CADILA HEALTHCARE has posted a net profit of Rs 829 m (down 79.3% YoY). Sales on the other hand came in at Rs 34 bn (up 13.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

AUROBINDO PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Nov 6, 2019 | Updated on Nov 6, 2019

Here's an analysis of the annual report of AUROBINDO PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

CADILA HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 28.9% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CADILA HEALTHCARE has posted a net profit of Rs 3 bn (down 28.9% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 38.6% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, AUROBINDO PHARMA has posted a net profit of Rs 6 bn (up 38.6% YoY). Sales on the other hand came in at Rs 54 bn (up 28.1% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

The One Trade I'm Most Bullish on Now

Nov 12, 2019

A highly specific trade to potentially triple your money in just three months. You won't find this information anywhere else!

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Nov 19, 2019 03:37 PM

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE - DR. DATSONS LABS COMPARISON

COMPARE CADILA HEALTHCARE WITH

MARKET STATS